Applications to the Fiscal Year 2016 (FY16) Multiple Sclerosis Research Program (MSRP) are being solicited for the Defense Health Agency, Research, Development, and Acquisition (DHA RDA) Directorate, by the U.S. Army Medical Research Acquisition Activity (USAMRAA). As directed by the Office of the Assistant Secretary of Defense for Health Affairs (OASD[HA]), the DHA RDA Directorate manages the Defense Health Program (DHP) Research, Development, Test, and Evaluation (RDT&E) appropriation. The managing agent for this Program Announcement/Funding Opportunity is the Congressionally Directed Medical Research Programs (CDMRP). The MSRP, established in FY09, is dedicated to supporting pioneering concepts and high-impact research that are relevant to the prevention, etiology, pathogenesis, assessment, and treatment of multiple sclerosis (MS) to ultimately lessen its personal and societal impact. Appropriations for the MSRP from FY09 through FY15 totaled $33.1 million (M). The FY16 appropriation is $6M.

Funding opportunities under this program:

• Pilot Clinical Trial Award
• Investigator Initiated Research Award
• Exploration - Hypothesis Development Award

The aim of the call is to support research which will improve the understanding of how different approaches to welfare secure the quality of life, especially of older people. A better understanding of these differences will help policymakers to identify potential ways of meeting needs, as models evolve in response to changing demographic pressures and circumstances.

Relevant Research Areas

Proposals must address one or more of these three research topics:

• Understanding wellbeing: how appropriate are current measures of wellbeing across the changing life course?
• Intergenerational relationships: how can welfare models distribute resources, rights and responsibilities in fair and sustainable ways?
• Welfare models: How can welfare models secure the health and wellbeing for older people confronted to caring needs, subject to frailty and nearing the end of life?

For more information, please consult the Joint Programming Initiative “More Years, Better Lives” (JPI-MYBL) website.

Call 2016: Welfare, Wellbeing and Demographic Change: Understanding Welfare Models

Application Deadline: April 12, 2016

Anticipated Notice of Decision: November 1, 2016

Funding Start Date: February 1, 2017

Funds Available: The total amount available for this funding opportunity is $1,500,000, enough to fund approximately up to 5 grants.

The maximum amount per grant is $300,000 - up to $100,000 per year over 3 years.

Of this $1,500,000:

• $1,000,000 is available to fund the Canadian component of applications relevant to the mandate of CIHR.
• $500,000 is available to fund the Canadian component of applications relevant to the mandate of the Social Sciences and Humanities Research Council (SSHRC).

Joint Programming is a new approach to foster collaboration and coordination in R&D in Europe and Canada and is a member-states driven activity. JPI-MYBL seeks to enhance coordination and collaboration between European and Canadian research programs related to demographic change.

Welfare models are deeply embedded in historical, cultural and economic contexts, and there are rarely simple transferable lessons. However, comparative studies can help us to understand the implications, strengths and weaknesses of particular institutional configurations, and how well they meet the needs of particular population groups. A better understanding of these differences can help policymakers identify potential ways of meeting needs, as their own models evolve in response to changing pressures and circumstances.

This is an international funding opportunity: Each proposal must involve a minimum of three eligible applicants from at least three different countries participating in the call. The maximum number of eligible participants in a project consortium is seven. The consortium should be reasonably balanced, not more than two eligible applicants per country/funding organization are allowed.

Participating countries: Austria, Belgium, Canada, Finland, France, Israel, Italy, Norway, Portugal, Spain, The Netherlands

Read more about this opportunity at JPI MYBL

The objective of this funding opportunity is  to bring together technologies and services to create Information and Communication Technology (ICT) based solutions with a clear route to market that will enable the wellbeing of people with dementia and their communities (family, caregivers, neighbourhood, service providers, care system, etc.).

For more information, please consult the Active and Assisted Living website.

Active and Assisted Living (AAL) Programme Call 2016

Living Well with Dementia

Application Deadline: May 26, 2016           

Anticipated Notice of Decision: November 30, 2016

Funding Start Date: October 1, 2016

Funds Available: The total Canadian amount available for this funding opportunity is $706,000 (CAD) enough to fund approximately two (2) grants. This amount may increase if additional funding partners participate.

• CIHR will contribute up to $117,666 (CAD) per year for 1 grant for a maximum of three years.
• AGE-WELL NCE will contribute up to $117,666 (CAD) per year for 1 grant for a maximum of three years.

The focus of the 2016 Call Challenge of the AAL Programme is to fund information and communication technology (ICT) based innovative, transnational and multi-disciplinary collaborative projects with a clear route to market that support people with dementia and their caregivers to live in dignity and provide satisfaction through all stages of dementia.

Eligibility: Consortium composition of at least 3 independent eligible organizations (legal entities), from at least 3 different AAL Partner States participating in the Call for Proposals; English as the language of the proposal

Partner countries: Austria, Belgium, Canada, Cyprus, Denmark,  France, Hungary, Ireland, Israel, Italy, Luxembourg, Netherlands, Norway, Poland, Romania, Portugal, Slovenia, Spain, Sweden, Switzerland and the United Kingdom.

CIHR Canadian Eligibility Requirements

A Partner Matching Tool is available to connect with other partner states. 
 

Information day: An informational webcast will be available online within a few days of March 8, 2016.

Info Day Webcast

AAL

The Active and Assisted Living (AAL) Programme is a common funding activity of member states of the AAL Association, with the financial support of the European Commission, based on article 185 of the Treaty on the Functioning of the European Union. The AAL Programme calls are complementary to the Horizon 2020 calls related to Active and Healthy Ageing under Societal Challenge 1.

The AAL Call 2016 is part of the AAL Programme that was approved in May 2014 by the European Parliament and the Council of the European Union. As part of the work-programme, the AAL is launching a Call for Proposals: “Living well with dementia: Providing integrated solutions based on information and communication technology to support the wellbeing of people living with dementia and their communities.”

Grand Challenges China: New Interventions for Global Health.  This challenge focuses on calls for innovative concepts for safe, effective, affordable and widely utilized interventions, such as vaccines and therapeutics, with the potential to protect against the acquisition, progression or transmission of infectious diseases that disproportionately affect the world’s poorest.  This call is in partnership with the National Natural Science Foundation of China and requires substantive collaborations between China-based investigators and those based outside of China.

Application deadline is March 15, 2016, 8:00 am Beijing time (March 14, 2016, 5pm Seattle time). For a detailed description of this challenge, please visit the Grand Challenges site.

This Knowledge to Action Grant has been created to encourage ideas that will close the gap between what is known from research and what is done with that knowledge in the health care community and public health practice. These grants are intended to provide funding for research projects that build on existing cancer research findings and aim to improve outcomes and experiences through knowledge translation (KT) for people and populations at risk, patients, their families and communities across the cancer trajectory e.g., to assist knowledge users (researchers, practitioners, policy makers, CCS program delivery staff and/or volunteers) in their awareness of knowledge or innovations and facilitating their use in health or healthcare system improvement. The grant should incorporate the principles of knowledge translation including knowledge synthesis, dissemination, exchange and/or ethically sound application of knowledge to improve health and the health system.

The goal of this grant program is to support and accelerate research and the application of new knowledge with imminent application potential relevant to cancer prevention in human populations. Proposed projects must demonstrate a specific and defined potential for impact on cancer incidence, for example through prevention/risk reduction research, programs, and practice, including interventions, knowledge translation, best practices and health-related decision making at the individual, organizational and health system levels. Applications are invited for social/psychosocial and behavioural science, health policy, population health, health promotion and health services research aimed at cancer prevention.

• Development of new methods for rapid multi-pathogen/multi-phenotype detection of multidrug-resistant organisms (MDROs) and nosocomial pathogens, and/or characterization of antimicrobial resistance patterns.
• Development of assays for host immune response biomarkers for diagnosis or prognosis.
• Development and preclinical testing of novel chemotypes (chemical classes/materials), biologics as potential therapeutics or prophylactics for wound infection, and/or biofilm formation, maintenance, or propagation.

• Evaluation of optimum preventive or directive therapies for combat-related or trauma-induced wound infections using Food and Drug Administration-approved drugs, biologics, or devices either alone or in combination.
• Evaluation of a functional prototype device or assay for the rapid detection of pathogens and/or microbial drug resistance markers.
• Evaluation of a functional prototype device or assay for the rapid detection of novel and specific in vivo or in vitro biomarkers (from wound, serum, saliva, or urine) that predict development of infection or discriminate between infection and colonization.

• Independent investigators at all academic levels (or equivalent).
• Both intramural and extramural investigators are encouraged to apply.

• A pre-application is required

• The FY17 MID-ARA intent is to support hypothesis-testing and/or proof-of-concept studies in in vitro and/or in vivo models, concept refinement, product candidate evaluation, maturation and/or down-selection, or completion of studies in support of IND/IDE applications.

• The anticipated funding limit is $2.0M total costs.

• The anticipated maximum period of performance is 3 years.

• Independent investigators at all academic levels (or equivalent). Both intramural and extramural investigators are encouraged to apply.

• A pre-application is required

• The FY17 MID-CTA intent is to support early phase clinical trials and medical device (including diagnostics) testing with the potential to have a major impact on prevention and treatment of combat-related or trauma induced wound infections.

• The anticipated funding limit is $2.5M total costs.

• The anticipated maximum period of performance is 3 years.

The National Wetland Conservation Fund (NWCF) supports Canadians in undertaking on-the-ground activities to restore and enhance wetlands in Canada. These activities must take place on private lands, municipal lands, provincial Crown lands, federal Crown lands in the Northwest Territories, Yukon, and Nunavut, or Aboriginal land across Canada.

The NWCF is one of several funding programs operated by Environment Canada for the conservation of natural habitats and wildlife. You can only receive funding from one federal funding program for each proposed activity. Any proposals submitted to the other federal funding programs, (Habitat Stewardship Program, Aboriginal Fund for Species at Risk, EcoAction, etc.) must be for different activities than those listed in your NWCF proposal.

Timelines

The program will be accepting expressions of interest until December 18, 2015. The submission of an expression of interest is strongly encouraged, particularly for applicants who have not received NWCF funding in the past.

The deadline for proposal submissions is January 15, 2016

The Operating Grants competition is the principal means by which the Cancer Research Society fulfills its mission to support fundamental, early translational and Environment-Cancer research on all types of cancer in order to contribute to the advancement of science aimed at preventing, detecting and treating this disease.